Aarey Drugs Pharmaceuticals Ltd vs Kobo Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 89.42 as of 06 May 15:30 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 8.3 on March 2021 to 23.9 on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 54.25 crore on March 2021 to ₹ 95.58 crore on March 2025 . This represents a CAGR of 11.99% over 5 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 17.63 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 100.61 crore as compare to the Sep '25 revenue of ₹ 84.95 crore. This represent the growth of 18.43% The revenue of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 2.67 crore as compare to the Sep '25 ebitda of ₹ 3.44 crore. This represent the decline of -22.38% The ebitda of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.24 crore to ₹ 0.57 crore over 7 quarters. This represents a CAGR of -35.86% The net profit of Kobo Biotech Ltd changed from ₹ -1.33 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Kobo Biotech Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 253 Cr while Market cap of Kobo Biotech Ltd is 6 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd?

As of May 6, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹89.42. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.71.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.